Rchr
J-GLOBAL ID:201201070973864612   Update date: Jan. 30, 2024

Morita Satoshi

モリタ サトシ | Morita Satoshi
Affiliation and department:
Job title: Professor
Research field  (1): Other
Research theme for competitive and other funds  (5):
  • 2020 - 2023 Cross-sectional and prospective study with metabolome analysis to detect pathophysiology about the relationship between deterioration in lung function and sleep disordered breathing
  • 2012 - 2016 Design and statistical analysis in translational clinical trials
  • 2012 - 2015 Bayesian study designs for new drug development in early-stage cancer clinical trials.
  • 2011 - 2013 A randomized controlled trial to establish a standard method for reconstruction after total gastrectomy
  • 2008 - 2010 Design and analysis of clinical studies for personalized medicine
Papers (650):
  • Don Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M Velaga, et al. Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients. British journal of cancer. 2024
  • Ayane Yamaguchi, Kosuke Kawaguchi, Kana Kawanishi, Yurina Maeshima, Akiyoshi Nakakura, Tatsuki R Kataoka, Sachiko Takahara, Shunsaku Nakagawa, Atsushi Yonezawa, Masahiro Takada, et al. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis. Breast cancer research and treatment. 2023
  • 河口 浩介, 前島 佑里奈, 藤本 優里, 石黒 洋, 山神 和彦, 高原 祥子, 諏訪 裕文, 鳥井 雅恵, 永井 成勲, 相良 安昭, et al. 乳癌免疫療法の課題と展望 免疫療法としてのCDK4/6阻害薬 腸内細菌叢と循環免疫プロファイルの観点から. 日本乳癌学会総会プログラム抄録集. 2023. 31回. 19-19
  • Katsunori Sakamoto, Toru Beppu, Goro Honda, Kenjiro Kotake, Masakazu Yamamoto, Keiichi Takahashi, Itaru Endo, Kiyoshi Hasegawa, Michio Itabashi, Yojiro Hashiguchi, et al. Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japan. Journal of hepato-biliary-pancreatic sciences. 2023. 30. 5. 570-590
  • Nobuyuki Katakami, Takashi Nishimura, Yu Hidaka, Akito Hata, Kazumi Nishino, Masahide Mori, Tomonori Hirashima, Naoto Takase, Toshihiko Kaneda, Hisashi Ohnishi, et al. Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312). Lung Cancer. 2023. 107261-107261
more...
MISC (299):
  • 砂留 広伸, 松本 久子, 村瀬 公彦, 田原 康玄, 西 健太, 寺田 悟, 野村 奈都子, 古郷 摩利子, 田嶋 範之, 森本 千絵, et al. 気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係 ながはまスタディ. アレルギー. 2021. 70. 6-7. 804-804
  • 砂留 広伸, 松本 久子, 村瀬 公彦, 田原 康玄, 西 健太, 寺田 悟, 野村 奈都子, 古郷 摩利子, 田嶋 範之, 森本 千絵, et al. 気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係 ながはまスタディ. アレルギー. 2021. 70. 6-7. 804-804
  • 砂留 広伸, 村瀬 公彦, 田原 康玄, 南 卓馬, 武山 博文, 高橋 順美, 松本 健, 濱田 哲, 長崎 忠雄, 谷澤 公伸, et al. 睡眠呼吸障害のバイオマーカーとしての血清尿酸値の有用性の検討 ながはまスタディ. 日本呼吸器学会誌. 2021. 10. 増刊. 206-206
  • 村瀬 公彦, 陳 和夫, 赤星 俊樹, 津田 徹, 大井 元晴, 外山 善朗, 成井 浩司, 富田 康弘, 大平 徹郎, 葛西 隆敏, et al. 睡眠時無呼吸患者に対する遠隔モニタリングシステムを利用した体重減量指導の効果 多施設共同無作為化比較試験. 日本呼吸器学会誌. 2021. 10. 増刊. 206-206
  • Yutaka Yamamoto, Hiroji Iwata, Taira Naruto, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, et al. A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study. CANCER RESEARCH. 2021. 81. 4
more...
Books (11):
  • Encyclopedia of Biopharmaceutical Statistics, 3rd Edition
    Informa Healthcare 2010
  • 消火器癌化学療法
    南山堂 2009
  • QOL評価学-測定, 解析, 解釈のすべて
    中山書店 2005
  • 癌治療の新たな試み 新編III
    医薬ジャーナル社 2005
  • 腎臓病: 先端医療シリーズ
    先端医療技術研究所 2005
more...
Lectures and oral presentations  (7):
  • Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial.
    (CEN-ISBS Conference 2017)
  • Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem
    (The Ninth ICSA International Conference 2013)
  • Bridging dose-finding for a multinational cancer phase I trial
    (Society for Clinical Trials 34th Annual Meeting 2013)
  • Bayesian study designs for new drug development
    (ISBA 2012 World Meeting 2012)
  • Sequential dose-finding in phase I clinical trials in Japan: East meets West
    (The 2011 Society for Clinical Trials Meeting 2011)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page